Semin Reprod Med 2012; 30(01): 32-38
DOI: 10.1055/s-0031-1299595
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Ovarian Actions of Estrogen Receptor-β: An Update

Ann E. Drummond
1   Prince Henry’s Institute of Medical Research, Clayton, Victoria, Australia
,
Peter J. Fuller
1   Prince Henry’s Institute of Medical Research, Clayton, Victoria, Australia
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
23. Januar 2012 (online)

Abstract

Estrogen is essential for folliculogenesis with independent roles attributed to each of the two estrogen receptors (ERs). ERβ, expressed predominantly by the ovarian granulosa cells, is required for antrum formation, preovulatory follicle maturation, expression of genes involved in ovarian differentiation (luteinizing hormone, aromatase, etc.), and follicle rupture during ovulation. Ovulatory dysfunction is associated with polymorphisms of the ERβ gene, and endocrine disruptors that selectively activate ERβ cause reproductive dysfunction and impairment fertility. ERβ may also exhibit antitumorigenic properties, with a decline in ERβ levels in epithelial ovarian cancers associated with more severe disease and poor prognosis. In this review, we examine the models that have been used to elucidate the roles ERβ plays in the ovary and consider the clinical consequences of altered ERβ expression or inappropriate activation of ERβ signaling.

 
  • References

  • 1 Richards JS. Maturation of ovarian follicles: actions and interactions of pituitary and ovarian hormones on follicular cell differentiation. Physiol Rev 1980; 60 (1) 51-89
  • 2 Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A 1996; 93 (12) 5925-5930
  • 3 Mosselman S, Polman J, Dijkema R. ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett 1996; 392 (1) 49-53
  • 4 Couse JF, Lindzey J, Grandien K, Gustafsson JA, Korach KS. Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. Endocrinology 1997; 138 (11) 4613-4621
  • 5 Couse JF, Curtis Hewitt S, Korach KS. Receptor null mice reveal contrasting roles for estrogen receptor alpha and beta in reproductive tissues. J Steroid Biochem Mol Biol 2000; 74 (5) 287-296
  • 6 Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci U S A 1993; 90 (23) 11162-11166
  • 7 Krege JH, Hodgin JB, Couse JF , et al. Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci U S A 1998; 95 (26) 15677-15682
  • 8 Couse JF, Hewitt SC, Bunch DO , et al. Postnatal sex reversal of the ovaries in mice lacking estrogen receptors alpha and beta. Science 1999; 286 (5448) 2328-2331
  • 9 Dupont S, Krust A, Gansmuller A, Dierich A, Chambon P, Mark M. Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development 2000; 127 (19) 4277-4291
  • 10 Fisher CR, Graves KH, Parlow AF, Simpson ER. Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc Natl Acad Sci U S A 1998; 95 (12) 6965-6970
  • 11 Britt KL, Drummond AE, Cox VA , et al. An age-related ovarian phenotype in mice with targeted disruption of the Cyp 19 (aromatase) gene. Endocrinology 2000; 141 (7) 2614-2623
  • 12 Kuiper GG, Carlsson B, Grandien K , et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997; 138 (3) 863-870
  • 13 Harris HA. Estrogen receptor-beta: recent lessons from in vivo studies. Mol Endocrinol 2007; 21 (1) 1-13
  • 14 Chu S, Fuller PJ. Identification of a splice variant of the rat estrogen receptor beta gene. Mol Cell Endocrinol 1997; 132 (1–2) 195-199
  • 15 Petersen DN, Tkalcevic GT, Koza-Taylor PH, Turi TG, Brown TA. Identification of estrogen receptor beta2, a functional variant of estrogen receptor beta expressed in normal rat tissues. Endocrinology 1998; 139 (3) 1082-1092
  • 16 Matthews J, Gustafsson JA. Estrogen signaling: a subtle balance between ER alpha and ER beta. Mol Interv 2003; 3 (5) 281-292
  • 17 Poola I, Abraham J, Baldwin K, Saunders A, Bhatnagar R. Estrogen receptors beta4 and beta5 are full length functionally distinct ERbeta isoforms: cloning from human ovary and functional characterization. Endocrine 2005; 27 (3) 227-238
  • 18 Zhao C, Toresson G, Xu L, Koehler KF, Gustafsson JA, Dahlman-Wright K. Mouse estrogen receptor beta isoforms exhibit differences in ligand selectivity and coactivator recruitment. Biochemistry 2005; 44 (22) 7936-7944
  • 19 Zhao C, Dahlman-Wright K, Gustafsson JA. Estrogen receptor beta: an overview and update. Nucl Recept Signal 2008; 6: e003
  • 20 Lu B, Leygue E, Dotzlaw H, Murphy LJ, Murphy LC, Watson PH. Estrogen receptor-beta mRNA variants in human and murine tissues. Mol Cell Endocrinol 1998; 138 (1-2) 199-203
  • 21 Maruyama K, Endoh H, Sasaki-Iwaoka H , et al. A novel isoform of rat estrogen receptor beta with 18 amino acid insertion in the ligand binding domain as a putative dominant negative regular of estrogen action. Biochem Biophys Res Commun 1998; 246 (1) 142-147
  • 22 Moore JT, McKee DD, Slentz-Kesler K , et al. Cloning and characterization of human estrogen receptor beta isoforms. Biochem Biophys Res Commun 1998; 247 (1) 75-78
  • 23 Ogawa S, Inoue S, Watanabe T , et al. Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor of estrogen action in human. Nucleic Acids Res 1998; 26 (15) 3505-3512
  • 24 Inoue S, Ogawa S, Horie K , et al. An estrogen receptor beta isoform that lacks exon 5 has dominant negative activity on both ERalpha and ERbeta. Biochem Biophys Res Commun 2000; 279 (3) 814-819
  • 25 Poola I, Abraham J, Baldwin K. Identification of ten exon deleted ERbeta mRNAs in human ovary, breast, uterus and bone tissues: alternate splicing pattern of estrogen receptor beta mRNA is distinct from that of estrogen receptor alpha. FEBS Lett 2002; 516 (1-3) 133-138
  • 26 Pettersson K, Grandien K, Kuiper GG, Gustafsson JA. Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha. Mol Endocrinol 1997; 11 (10) 1486-1496
  • 27 Emmen JM, Couse JF, Elmore SA, Yates MM, Kissling GE, Korach KS. In vitro growth and ovulation of follicles from ovaries of estrogen receptor (ER)alpha and ERbeta null mice indicate a role for ERbeta in follicular maturation. Endocrinology 2005; 146 (6) 2817-2826
  • 28 Hegele-Hartung C, Siebel P, Peters O , et al. Impact of isotype-selective estrogen receptor agonists on ovarian function. Proc Natl Acad Sci U S A 2004; 101 (14) 5129-5134
  • 29 Sundarrajan C, Liao WX, Roy AC, Ng SC. Association between estrogen receptor-beta gene polymorphisms and ovulatory dysfunctions in patients with menstrual disorders. J Clin Endocrinol Metab 2001; 86 (1) 135-139
  • 30 Couse JF, Yates MM, Sanford R, Nyska A, Nilson JH, Korach KS. Formation of cystic ovarian follicles associated with elevated luteinizing hormone requires estrogen receptor-beta. Endocrinology 2004; 145 (10) 4693-4702
  • 31 Nakamura T, Katsu Y, Watanabe H, Iguchi T. Estrogen receptor subtypes selectively mediate female mouse reproductive abnormalities induced by neonatal exposure to estrogenic chemicals. Toxicology 2008; 253 (1–3) 117-124
  • 32 Jefferson WN, Couse JF, Padilla-Banks E, Korach KS, Newbold RR. Neonatal exposure to genistein induces estrogen receptor (ER)alpha expression and multioocyte follicles in the maturing mouse ovary: evidence for ERbeta-mediated and nonestrogenic actions. Biol Reprod 2002; 67 (4) 1285-1296
  • 33 Kim H, Hayashi S, Chambon P, Watanabe H, Iguchi T, Sato T. Effects of diethylstilbestrol on ovarian follicle development in neonatal mice. Reprod Toxicol 2009; 27 (1) 55-62
  • 34 Hosokawa K, Ottander U, Wahlberg P, Ny T, Cajander S, Olofsson IJ. Dominant expression and distribution of oestrogen receptor beta over oestrogen receptor alpha in the human corpus luteum. Mol Hum Reprod 2001; 7 (2) 137-145
  • 35 van den Driesche S, Smith VM, Myers M, Duncan WC. Expression and regulation of oestrogen receptors in the human corpus luteum. Reproduction 2008; 135 (4) 509-517
  • 36 Byers M, Kuiper GG, Gustafsson JA, Park-Sarge OK. Estrogen receptor-beta mRNA expression in rat ovary: down-regulation by gonadotropins. Mol Endocrinol 1997; 11 (2) 172-182
  • 37 Drummond AE, Baillie AJ, Findlay JK. Ovarian estrogen receptor alpha and beta mRNA expression: impact of development and estrogen. Mol Cell Endocrinol 1999; 149 (1-2) 153-161
  • 38 Yang P, Kriatchko A, Roy SK. Expression of ER-alpha and ER-beta in the hamster ovary: differential regulation by gonadotropins and ovarian steroid hormones. Endocrinology 2002; 143 (6) 2385-2398
  • 39 Juengel JL, Heath DA, Quirke LD, McNatty KP. Oestrogen receptor alpha and beta, androgen receptor and progesterone receptor mRNA and protein localisation within the developing ovary and in small growing follicles of sheep. Reproduction 2006; 131 (1) 81-92
  • 40 Słomczyńska M, Duda M, Galas J. Estrogen receptor alpha and beta expression in the porcine ovary. Folia Histochem Cytobiol 2001; 39 (2) 137-138
  • 41 Pepe GJ, Billiar RB, Leavitt MG, Zachos NC, Gustafsson JA, Albrecht ED. Expression of estrogen receptors alpha and beta in the baboon fetal ovary. Biol Reprod 2002; 66 (4) 1054-1060
  • 42 Rosenfeld CS, Yuan X, Manikkam M, Calder MD, Garverick HA, Lubahn DB. Cloning, sequencing, and localization of bovine estrogen receptor-beta within the ovarian follicle. Biol Reprod 1999; 60 (3) 691-697
  • 43 Monje P, Boland R. Subcellular distribution of native estrogen receptor alpha and beta isoforms in rabbit uterus and ovary. J Cell Biochem 2001; 82 (3) 467-479
  • 44 Pelletier G, El-Alfy M. Immunocytochemical localization of estrogen receptors alpha and beta in the human reproductive organs. J Clin Endocrinol Metab 2000; 85 (12) 4835-4840
  • 45 Tremblay GB, Tremblay A, Copeland NG , et al. Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta. Mol Endocrinol 1997; 11 (3) 353-365
  • 46 Tetsuka M, Milne M, Hillier SG. Expression of oestrogen receptor isoforms in relation to enzymes of oestrogen synthesis in rat ovary. Mol Cell Endocrinol 1998; 141 (1-2) 29-35
  • 47 Hild-Petito S, Stouffer RL, Brenner RM. Immunocytochemical localization of estradiol and progesterone receptors in the monkey ovary throughout the menstrual cycle. Endocrinology 1988; 123 (6) 2896-2905
  • 48 Revelli A, Pacchioni D, Cassoni P, Bussolati G, Massobrio M. In situ hybridization study of messenger RNA for estrogen receptor and immunohistochemical detection of estrogen and progesterone receptors in the human ovary. Gynecol Endocrinol 1996; 10 (3) 177-186
  • 49 Brandenberger AW, Tee MK, Jaffe RB. Estrogen receptor alpha (ER-alpha) and beta (ER-beta) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: down-regulation of ER-beta in neoplastic tissues. J Clin Endocrinol Metab 1998; 83 (3) 1025-1028
  • 50 Hillier SG, Anderson RA, Williams AR, Tetsuka M. Expression of oestrogen receptor alpha and beta in cultured human ovarian surface epithelial cells. Mol Hum Reprod 1998; 4 (8) 811-815
  • 51 Drummond AE, Dyson M, Mercer JE, Findlay JK. Differential responses of post-natal rat ovarian cells to FSH and activin. Mol Cell Endocrinol 1996; 122 (1) 21-32
  • 52 Sar M, Welsch F. Differential expression of estrogen receptor-beta and estrogen receptor-alpha in the rat ovary. Endocrinology 1999; 140 (2) 963-971
  • 53 Kouzu-Fujita M, Mezaki Y, Sawatsubashi S , et al. Coactivation of estrogen receptor beta by gonadotropin-induced cofactor GIOT-4. Mol Cell Biol 2009; 29 (1) 83-92
  • 54 Chang EC, Frasor J, Komm B, Katzenellenbogen BS. Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells. Endocrinology 2006; 147 (10) 4831-4842
  • 55 Hall JM, Korach KS. Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells. Mol Endocrinol 2003; 17 (5) 792-803
  • 56 Couse JF, Yates MM, Walker VR, Korach KS. Characterization of the hypothalamic-pituitary-gonadal axis in estrogen receptor (ER) null mice reveals hypergonadism and endocrine sex reversal in females lacking ERalpha but not ERbeta. Mol Endocrinol 2003; 17 (6) 1039-1053
  • 57 Couse JF, Yates MM, Deroo BJ, Korach KS. Estrogen receptor-beta is critical to granulosa cell differentiation and the ovulatory response to gonadotropins. Endocrinology 2005; 146 (8) 3247-3262
  • 58 Inzunza J, Morani A, Cheng G , et al. Ovarian wedge resection restores fertility in estrogen receptor beta knockout (ERbeta-/-) mice. Proc Natl Acad Sci U S A 2007; 104 (2) 600-605
  • 59 Cheng G, Weihua Z, Mäkinen S , et al. A role for the androgen receptor in follicular atresia of estrogen receptor beta knockout mouse ovary. Biol Reprod 2002; 66 (1) 77-84
  • 60 Deroo BJ, Rodriguez KF, Couse JF , et al. Estrogen receptor beta is required for optimal cAMP production in mouse granulosa cells. Mol Endocrinol 2009; 23 (7) 955-965
  • 61 Rodriguez KF, Couse JF, Jayes FL , et al. Insufficient luteinizing hormone-induced intracellular signaling disrupts ovulation in preovulatory follicles lacking estrogen receptor-beta. Endocrinology 2010; 151 (6) 2826-2834
  • 62 Britt KL, Findlay JK. Estrogen actions in the ovary revisited. J Endocrinol 2002; 175 (2) 269-276
  • 63 Britt KL, Kerr J, O’Donnell L , et al. Estrogen regulates development of the somatic cell phenotype in the eutherian ovary. FASEB J 2002; 16 (11) 1389-1397
  • 64 Franks S, Stark J, Hardy K. Follicle dynamics and anovulation in polycystic ovary syndrome. Hum Reprod Update 2008; 14 (4) 367-378
  • 65 Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med 2010; 8: 41
  • 66 Jakimiuk AJ, Weitsman SR, Yen HW, Bogusiewicz M, Magoffin DA. Estrogen receptor alpha and beta expression in theca and granulosa cells from women with polycystic ovary syndrome. J Clin Endocrinol Metab 2002; 87 (12) 5532-5538
  • 67 Zurvarra FM, Salvetti NR, Mason JI, Velazquez MM, Alfaro NS, Ortega HH. Disruption in the expression and immunolocalisation of steroid receptors and steroidogenic enzymes in letrozole-induced polycystic ovaries in rat. Reprod Fertil Dev 2009; 21 (7) 827-839
  • 68 Kim JJ, Choi YM, Choung SH, Yoon SH, Lee GH, Moon SY. Estrogen receptor beta gene + 1730 G/A polymorphism in women with polycystic ovary syndrome. Fertil Steril 2010; 93 (6) 1942-1947
  • 69 Li AJ, Baldwin RL, Karlan BY. Estrogen and progesterone receptor subtype expression in normal and malignant ovarian epithelial cell cultures. Am J Obstet Gynecol 2003; 189 (1) 22-27
  • 70 Lindgren PR, Cajander S, Bäckström T, Gustafsson JA, Mäkelä S, Olofsson JI. Estrogen and progesterone receptors in ovarian epithelial tumors. Mol Cell Endocrinol 2004; 221 (1–2) 97-104
  • 71 Lazennec G. Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis. Cancer Lett 2006; 231 (2) 151-157
  • 72 Bardin A, Boulle N, Lazennec G, Vignon F, Pujol P. Loss of ERbeta expression as a common step in estrogen-dependent tumor progression. Endocr Relat Cancer 2004; 11 (3) 537-551
  • 73 Chan KK, Wei N, Liu SS, Xiao-Yun L, Cheung AN, Ngan HY. Estrogen receptor subtypes in ovarian cancer: a clinical correlation. Obstet Gynecol 2008; 111 (1) 144-151
  • 74 Fox EM, Davis RJ, Shupnik MA. ERbeta in breast cancer—onlooker, passive player, or active protector?. Steroids 2008; 73 (11) 1039-1051
  • 75 Treeck O, Pfeiler G, Mitter D, Lattrich C, Piendl G, Ortmann O. Estrogen receptor beta1 exerts antitumoral effects on SK-OV-3 ovarian cancer cells. J Endocrinol 2007; 193 (3) 421-433
  • 76 Vendrell JA, Magnino F, Danis E , et al. Estrogen regulation in human breast cancer cells of new downstream gene targets involved in estrogen metabolism, cell proliferation and cell transformation. J Mol Endocrinol 2004; 32 (2) 397-414
  • 77 Hayashido Y, Lucas A, Rougeot C, Godyna S, Argraves WS, Rochefort H. Estradiol and fibulin-1 inhibit motility of human ovarian- and breast-cancer cells induced by fibronectin. Int J Cancer 1998; 75 (4) 654-658
  • 78 Suzuki F, Akahira J, Miura I , et al. Loss of estrogen receptor beta isoform expression and its correlation with aberrant DNA methylation of the 5′-untranslated region in human epithelial ovarian carcinoma. Cancer Sci 2008; 99 (12) 2365-2372
  • 79 Yap OW, Bhat G, Liu L, Tollefsbol TO. Epigenetic modifications of the estrogen receptor beta gene in epithelial ovarian cancer cells. Anticancer Res 2009; 29 (1) 139-144
  • 80 Chu S, Mamers P, Burger HG, Fuller PJ. Estrogen receptor isoform gene expression in ovarian stromal and epithelial tumors. J Clin Endocrinol Metab 2000; 85 (3) 1200-1205
  • 81 Fuller PJ, Chu S, Fikret S, Burger HG. Molecular pathogenesis of granulosa cell tumours. Mol Cell Endocrinol 2002; 191 (1) 89-96
  • 82 Fuller PJ, Chu S. Signalling pathways in the molecular pathogenesis of ovarian granulosa cell tumours. Trends Endocrinol Metab 2004; 15 (3) 122-128
  • 83 Alexiadis M, Eriksson N, Jamieson S , et al. Nuclear receptor profiling of ovarian granulosa cell tumors. Horm Cancer 2011; 2 (3) 157-169
  • 84 Chu S, Nishi Y, Yanase T, Nawata H, Fuller PJ. Transrepression of estrogen receptor beta signaling by nuclear factor-kappab in ovarian granulosa cells. Mol Endocrinol 2004; 18 (8) 1919-1928
  • 85 Wang Y, Chan S, Tsang BK. Involvement of inhibitory nuclear factor-kappaB (NFkappaB)-independent NFkappaB activation in the gonadotropic regulation of X-linked inhibitor of apoptosis expression during ovarian follicular development in vitro. Endocrinology 2002; 143 (7) 2732-2740
  • 86 Schumer ST, Cannistra SA. Granulosa cell tumor of the ovary. J Clin Oncol 2003; 21 (6) 1180-1189
  • 87 Kuiper GG, Shughrue PJ, Merchenthaler I, Gustafsson JA. The estrogen receptor beta subtype: a novel mediator of estrogen action in neuroendocrine systems. Front Neuroendocrinol 1998; 19 (4) 253-286
  • 88 Brzozowski AM, Pike AC, Dauter Z , et al. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 1997; 389 (6652) 753-758
  • 89 Price KR, Fenwick GR. Naturally occurring oestrogens in foods—a review. Food Addit Contam 1985; 2 (2) 73-106
  • 90 Whitten PL, Naftolin F. Reproductive actions of phytoestrogens. Baillieres Clin Endocrinol Metab 1998; 12 (4) 667-690
  • 91 Whitten PL, Patisaul HB. Cross-species and interassay comparisons of phytoestrogen action. Environ Health Perspect 2001; 109 (Suppl 1) 5-20
  • 92 Martin C, Ross M, Chapman KE , et al. CYP7B generates a selective estrogen receptor beta agonist in human prostate. J Clin Endocrinol Metab 2004; 89 (6) 2928-2935
  • 93 Britt KL, Simpson ER, Findlay JK. Effects of phytoestrogens on the ovarian and pituitary phenotypes of estrogen-deficient female aromatase knockout mice. Menopause 2005; 12 (2) 174-185
  • 94 Saunders PT, Maguire SM, Gaughan J, Millar MR. Expression of oestrogen receptor beta (ER beta) in multiple rat tissues visualised by immunohistochemistry. J Endocrinol 1997; 154 (3) R13-R16
  • 95 Wang H, Masironi B, Eriksson H, Sahlin L. A comparative study of estrogen receptors alpha and beta in the rat uterus. Biol Reprod 1999; 61 (4) 955-964
  • 96 Matsuzaki S, Fukaya T, Suzuki T, Murakami T, Sasano H, Yajima A. Oestrogen receptor alpha and beta mRNA expression in human endometrium throughout the menstrual cycle. Mol Hum Reprod 1999; 5 (6) 559-564
  • 97 Sasano H, Suzuki T, Matsuzaki Y , et al. Messenger ribonucleic acid in situ hybridization analysis of estrogen receptors alpha and beta in human breast carcinoma. J Clin Endocrinol Metab 1999; 84 (2) 781-785
  • 98 Jefferson WN, Padilla-Banks E, Newbold RR. Disruption of the female reproductive system by the phytoestrogen genistein. Reprod Toxicol 2007; 23 (3) 308-316
  • 99 Jefferson WN, Padilla-Banks E, Newbold RR. Disruption of the developing female reproductive system by phytoestrogens: genistein as an example. Mol Nutr Food Res 2007; 51 (7) 832-844
  • 100 Shirwalkar H, Modi DN, Maitra A. Exposure of adult rats to estradiol valerate induces ovarian cyst with early senescence of follicles. Mol Cell Endocrinol 2007; 272 (1–2) 22-37
  • 101 Fuortes L, Clark MK, Kirchner HL, Smith EM. Association between female infertility and agricultural work history. Am J Ind Med 1997; 31 (4) 445-451
  • 102 Younglai EV, Holloway AC, Foster WG. Environmental and occupational factors affecting fertility and IVF success. Hum Reprod Update 2005; 11 (1) 43-57
  • 103 Zama AM, Uzumcu M. Fetal and neonatal exposure to the endocrine disruptor methoxychlor causes epigenetic alterations in adult ovarian genes. Endocrinology 2009; 150 (10) 4681-4691
  • 104 Gray Jr LE, Ostby J, Ferrell J , et al. A dose-response analysis of methoxychlor-induced alterations of reproductive development and function in the rat. Fundam Appl Toxicol 1989; 12 (1) 92-108
  • 105 Armenti AE, Zama AM, Passantino L, Uzumcu M. Developmental methoxychlor exposure affects multiple reproductive parameters and ovarian folliculogenesis and gene expression in adult rats. Toxicol Appl Pharmacol 2008; 233 (2) 286-296
  • 106 Waters KM, Safe S, Gaido KW. Differential gene expression in response to methoxychlor and estradiol through ERalpha, ERbeta, and AR in reproductive tissues of female mice. Toxicol Sci 2001; 63 (1) 47-56
  • 107 Gaido KW, Maness SC, McDonnell DP, Dehal SS, Kupfer D, Safe S. Interaction of methoxychlor and related compounds with estrogen receptor alpha and beta, and androgen receptor: structure-activity studies. Mol Pharmacol 2000; 58 (4) 852-858
  • 108 Safe SH, Pallaroni L, Yoon K , et al. Toxicology of environmental estrogens. Reprod Fertil Dev 2001; 13 (4) 307-315
  • 109 Kang JH, Kondo F, Katayama Y. Human exposure to bisphenol A. Toxicology 2006; 226 (2-3) 79-89
  • 110 Kurosawa T, Hiroi H, Tsutsumi O , et al. The activity of bisphenol A depends on both the estrogen receptor subtype and the cell type. Endocr J 2002; 49 (4) 465-471
  • 111 Kato H, Ota T, Furuhashi T, Ohta Y, Iguchi T. Changes in reproductive organs of female rats treated with bisphenol A during the neonatal period. Reprod Toxicol 2003; 17 (3) 283-288
  • 112 Iguchi T. Cellular effects of early exposure to sex hormones and antihormones. Int Rev Cytol 1992; 139: 1-57
  • 113 Kim H, Nakajima T, Hayashi S , et al. Effects of diethylstilbestrol on programmed oocyte death and induction of polyovular follicles in neonatal mouse ovaries. Biol Reprod 2009; 81 (5) 1002-1009
  • 114 Henry LA, Witt DM. Resveratrol: phytoestrogen effects on reproductive physiology and behavior in female rats. Horm Behav 2002; 41 (2) 220-228
  • 115 Bowers JL, Tyulmenkov VV, Jernigan SC, Klinge CM. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta. Endocrinology 2000; 141 (10) 3657-3667